GlassScriptPhysician profile
Maria Mcintire
NPI 1356531107
$1,144.27
in general payments reported to CMS, 2019-2025
13 companies · $44.59 in 2025
The $44.59 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $353 · 2021: $150 · 2022: $134 · 2023: $66.86 · 2024: $15.62 · 2025: $44.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $308.08 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $219.93 | 2019-2022 | |
| Janssen Biotech, INC. | $181.20 | 2019-2023 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $178.82 | 2019-2024 | Entyvio, Gattex |
| Redhill Biopharma INC. | $74.88 | 2020 | |
| Shire North American Group INC | $35.97 | 2019 | |
| Evoke Pharma, INC. | $35.61 | 2021-2025 | |
| Lilly USA, LLC | $26.07 | 2025 | Omvoh |
| Gilead Sciences, INC. | $24.37 | 2020 | |
| Alnylam Pharmaceuticals INC. | $17.72 | 2022 | |
| Exact Sciences Corporation | $17.64 | 2023 | Cologuard Collection Kit |
| Shionogi INC | $12.83 | 2019 | |
| Ucb, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Mcintire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.